ライフサイエンスコーパス: experimental group

1 sted for proficiency on days 10, 20, and 30 (experimental group).

2 ontrol group) or FOLFOXIRI plus bevacizumab (experimental group).

3 cerebroventricular and intra-PFC) (n = 10-12/experimental group).

4 lus bevacizumab (5 mg/kg every 2 weeks x 26, experimental group).

5 nonmalignant part of the surgical specimen (experimental group).

6 nt regimen combined with HAPa immunotherapy (experimental group).

7 ost-test and 3 months after post-test in the experimental group.

8 simultaneously in either the control or the experimental group.

9 neutropenia were significantly higher in the experimental group.

10 ropriate subset of outliers to represent the experimental group.

11 tected in calretinin-positive neurons in any experimental group.

12 h recombinant CPNE7 protein for 5 min as the experimental group.

13 symptoms were also better controlled in the experimental group.

14 least 5 sample replicates were used for each experimental group.

15 oluble CD40 ligand were also observed in the experimental group.

16 tion response to KCl and endothelin for each experimental group.

17 se bengal, riboflavin, or water according to experimental group.

18 ined equal in other OB-layers throughout all experimental groups.

19 frequency flux noise measurements of various experimental groups.

20 ological analyses in comparison to the other experimental groups.

21 imultaneously classify samples from multiple experimental groups.

22 n of muscle samples did not differ among the experimental groups.

23 behaviors between animals in the control and experimental groups.

24 ccessibility, as compared with that of other experimental groups.

25 ges did not significantly differ between the experimental groups.

26 rol particularly LDL cholesterol observed in experimental groups.

27 levels did not significantly differ between experimental groups.

28 after attaining steady [Ca(2+)](SR) in both experimental groups.

29 essments should be identical for control and experimental groups.

30 y rats were divided among control, sham, and experimental groups.

31 able until the end of the experiment for all experimental groups.

32 ersion of CO(2) has been studied by numerous experimental groups.

33 differences in feed efficiency ratios among experimental groups.

34 /Fet-/- mice that were placed in control and experimental groups.

35 ables of myosin VI motility reported by four experimental groups.

36 significant differences between control and experimental groups.

37 For this purpose, we first defined four experimental groups.

38 sites after 21 days differed for each of the experimental groups.

39 d XY littermates (n=8) were separated into 5 experimental groups.

40 sponse relationship was not available in all experimental groups.

41 lated OT-1/GFP group compared with all other experimental groups.

42 were present in both hemispheres of all the experimental groups.

43 ve patients were selected and divided into 3 experimental groups.

44 nd PC-O(34:1), was 30-100% higher across all experimental groups.

45 in information about the differences between experimental groups.

46 pressure was similar among all hypertensive experimental groups.

47 ing very differing lipid metabolism in the 4 experimental groups.

48 s showed the development of periodontitis in experimental groups.

49 e NMDA-DeltaCa(2+) responses between the two experimental groups.

50 mab (5 mg/kg every 2 weeks for 52 weeks [ie, experimental group]).

51 insonian motor symptoms in either of the two experimental groups (1-methyl-4-phenyl-1,2,3,6-tetrahydr

52 Rats were randomly assigned to one of five experimental groups: 1) acutely anesthetized control, 2)

53 Twenty-one animals were randomized to three experimental groups: 1) Local cooling with water for 20

54 y rats were randomly assigned to one of five experimental groups: (1) control (Con), (2) 6 h of MV, (

55 de immunodeficient mice were split into four experimental groups: (1) IR alone (IR only), (2) DFO tre

56 d in control (group 1, periosteum alone) and experimental (group 2, periosteum with alloplastic graft

57 death occurred in 56 of 257 patients in the experimental group (21.8%), as compared with 58 of 260 p

58 rence in the risk of an unfavorable outcome (experimental group [21.0%] minus control group [17.2%])

59 response (AUC: control group 817 +/- 107 and experimental group 3,445 +/- 573 pg x ml(-1) x 90 min(-1

60 ory T (Treg)-cells was increased only in the experimental group 30 days after infection.

61 was longer, but not significantly so, in the experimental group (31.0 vs. 25.8 months; hazard ratio f

62 e curve [AUC]: control group 240 +/- 261 and experimental group 4,346 +/- 1,259 pg x ml(-1) x 90 min(

63 osis rates in 1, 2, 3, 4, and 5-years in the experimental group (6.9%, 11.5%, 19.1%, 26.0%, and 35.9%

64 In the experimental group, 65 healthy male and female subjects

65 ntly, the 4 and 5-year survival rates in the experimental group (83.2% and 76.3%, respectively) were

66 rticipants dropped out after assignment to 3 experimental groups; 90 participants were assigned to a

67 ed removal and replacement of individuals in experimental groups (a key method in testing for CCE) al

68 randomly assigned into one of the two 4-week experimental groups, a forced exercise group and a non-e

69 (n=8, each group) were randomized into four experimental groups: (a) conventional monopolar RF alone

70 rats were randomly allocated into four main experimental groups, according to mesh pore size in mum:

71 ed animals performed better than the other 3 experimental groups across 1 year of treatment.

72 group vs 43.1 [95% CI, 42.0 to 44.1] in the experimental group; adjusted difference, 4.9 [95% CI, 2.

73 e-pilocarpine injections and divided into an experimental group (administered by MK-801) and a positi

74 found lower all-cause mortality risk in the experimental group after age 40 [hazard ratio (HR) = 0.9

75 ical pathway proteins did not differ between experimental groups after 3 months of diabetes, while NF

76 Men in the experimental group also rated heavier female bodies as m

77 Participants in experimental groups also received usual care.

78 ts of each participant was -2.8 (7.2) in the experimental group and 10.7 (10.8) in the control group.

79 2018) was 12.4 months (IQR 8.3-21.7) in the experimental group and 11.3 months (8.0-18.4) in the sta

80 roup, among Hispanic participants (27 in the experimental group and 19 in the control group), there w

81 uction of excess arm volume was 29.0% in the experimental group and 22.6% in the control group (diffe

82 28 days, 277 of 501 patients (55.3%) in the experimental group and 251 of 509 patients (49.3%) in th

83 occurred in 33 (10%) of 332 patients in the experimental group and 28 (9%) of 329 in the standard gr

84 The objective response rate was 65% in the experimental group and 53% in the control group (P=0.006

85 75.6% (95% CI 73.7-77.5) of patients in the experimental group and 74.3% (72.3-76.2) of controls wer

86 d at euro218.30 (95%CI 150.52-286.08) in the experimental group and euro232.20 (95%CI: 203.80-260.60)

87 nfirmed by higher correlation coefficient of experimental group and mortality of challenged animals.

88 ood samples of females from any intravaginal experimental group and only detected in 20% of subcutane

89 o compare disease-free survival between each experimental group and placebo in the intention-to-treat

90 ere not significantly different between each experimental group and the respective control group at 2

91 nation therapy (treatment weeks 24-72 in the experimental group and weeks 48-96 in the control group)

92 d-type female mice were distributed into six experimental groups and sacrificed at 7, 15, and 30 days

93 monstrated the greatest peak loads among the experimental groups and the highest to date in a rabbit

94 pegylated liposomal doxorubicin-bevacizumab (experimental group) and 337 were randomly assigned to re

95 ts adhering to a particular blood type diet (experimental group) and participants continuing a standa

96 received 1 mg phylloquinone daily for 12 mo (experimental group), and 21 subjects were treated with a

97 /lesions over time decreased slightly in the experimental group, and increased slightly in the contro

98 In the second experimental group, animals received a purified diet wit

99 specimens were selected and divided into two experimental groups: animals with tough meat (TO) and an

100 n and puncture, mice were randomized to four experimental groups as follows: 1) sham control; 2) sham

101 nin-immunoreactive cells was similar for all experimental groups as well.

102 ays (interquartile range, 4.0 to 5.0) in the experimental group, as compared with 8.0 days (interquar

103 ression-free survival was 12.1 months in the experimental group, as compared with 9.7 months in the c

104 observed in the n3 FA content in egg yolk in experimental groups, as well as all PUFA (polyunsaturate

105 rvings per day), declined to nearly 0 in the experimental group at 1 year, and remained lower in the

106 n the mean CAL or PD values between the four experimental groups at baseline and 3 or 12 months post-

107 r, both measures of spatial recall separated experimental groups beyond what would be expected based

108 ant differences were noticed between the two experimental groups both for PD (P = 0.03) and clinical

109 n the standard group and 0.1 +/- 0.5% in the experimental group, but the overall time course of %BF d

110 of treatment, there was no mortality in the experimental group by week 5, and 67% of the experimenta

111 LIMK-1, cofilin-1, and beta-actin in all the experimental groups by semiquantitative and quantitative

112 All quantitative data were compared between experimental groups by using a mixed linear model and t

113 atios (SNRs) were compared between different experimental groups by using the Kruskal-Wallis test and

114 standard chow diet 7 days a week, while the experimental group (Chow/Palatable) is provided chow for

115 nts were seen in 517 of 2073 patients in the experimental group compared with 539 of 2089 controls (h

116 y significant improvements in outcome in the experimental group compared with control group at both 8

117 eactivity was significantly decreased in all experimental groups compared to the control groups (P <0

118 Six participants in the experimental group, compared with one in the control gro

119 The experimental group completed a 5-h training regime and t

120 All three experimental groups completed a 14-week intervention.

121 Participants undergoing a DBPCFC (experimental group) completed the FAQLQ and Food Allergy

122 The experimental group comprised three subgroups treated wit

123 luenza viruses, a ferret contact model using experimental groups comprised of one inoculated ferret a

124 This gave four experimental groups: Control (C), C+ADR, Dose 1+ADR, and

125 Sprague-Dawley rats were divided into three experimental groups: control (n = 5), irradiated homolog

126 Male rats were divided into four experimental groups: Control rats, CONTR-ARG rats, were

127 cFMA improvements in the experimental group correlated with changes in fMRI later

128 assigned 30 Sprague-Dawley rats to one of 5 experimental groups: corticotomy alone, corticotomy-assi

129 Furthermore, in none of these experimental groups did beta cell proliferation and isle

130 ol group compared with 1.93 +/- 0.37 for the experimental group) did not differ.

131 stereotypies were not observed in any of the experimental groups during the first year of life.

132 d collagen membrane with primary closure) or experimental group E (allograft covered with cross-linke

133 p (C; no periodontal therapy) (n = 35) or an experimental group (E; NSPT in the form of scaling and r

134 archers are interested in comparing multiple experimental groups (e.g. tumor size) with a reference g

135 s of infection and the mortality rate in the experimental group E2 receiving AuraShield L.

136 performance and lower mortality rates in the experimental group E2.

137 Each rat in the two experimental groups (early, late) was also yoked to a co

138 posure to the solution was contingent on the experimental groups entry into the goal box of the runwa

139 Experimental groups exhibited increases in: 1) total cho

140 In the experimental group, explants were microscopically devoid

141 A cross-over design was used with experimental groups fed high-starch (HS) or high-fibre (

142 l control, atherogenic control and six other experimental groups (fed atherogenic diet supplemented w

143 or to receive a fixed course of antibiotics (experimental group) for 4+/-1 calendar days.

144 In the experimental group (group 1), donor lungs were obtained

145 Those in the experimental group had 1 eye dilated and their optic ner

146 tial proficiency test, while students in the experimental group had a 91.7% pass rate at day 30 (P <

147 After the trial, the experimental group had higher mean scores in knowledge (

148 Thus, the experimental group had lower mortality from causes known

149 After age 40, the experimental group had lower mortality from overall canc

150 The placebo and experimental groups had significant differences in the 1

151 This study consisted of 28 rats and four experimental groups: healthy control group (C, n = 6); p

152 An experimental group heard nonspeech sound exemplars drawn

153 regulated by infection in the livers of both experimental groups; however, its levels were several-fo

154 t enzymatic degradation was observed for all experimental groups; however, statistically significant

155 in the standard group and 12.4 months in the experimental group (HR 1.33, 95% CI 0.72-1.78; P = 0.59)

156 ort if significant differences favouring the experimental group in a prespecified primary or secondar

157 r of replicates and the variance within each experimental group in clustering expression data, and pr

158 significant differences between control and experimental groups in both organism transcriptional act

159 ere no significant differences between the 2 experimental groups in radiographic root development ( P

160 , the effect of the person was less than the experimental group (in this case, sampling method) for a

161 Men were randomly assigned to either an experimental group, in which they took part in a task th

162 Experimental groups included non-allergic rats (NA) (n =

163 No other experimental groups, including riboflavin-mediated PDT,

164 Women in the experimental group increased physical activity from 1609

165 In an experimental group, infants were given the possibility t

166 In two further experimental groups, intentionality cues were removed by

167 entially abundant features between different experimental groups is a common goal for many metabolomi

168 gene expression profiles that differentiate experimental groups is critical for discovery and analys

169 ue at the site of injury was similar in both experimental groups (L2: 79% and T8: 82%).

170 The experimental group learned the discrimination and animal

171 elated deaths occurred in one patient in the experimental group (<1%; large intestine perforation) an

172 t, compared to controls, participants in the experimental group make more generous choices in an inde

173 atomical configurations in all zones of both experimental groups matched the functional circuit stren

174 ansected adult female rats and compared four experimental groups: media-untrained, media-trained, OEG

175 nificantly between the two groups (change in experimental group minus change in control group, -0.3;

176 Mice in the experimental group (n = 10) were administered azoxymetha

177 p (N=158) and 14.3 (12.6-16.3) months in the experimental group (N = 145) (hazard ratio [HR] 1.02, 95

178 After the 14-day treatment, the experimental group (n = 35) exhibited significantly lowe

179 The rate of diarrhea was 76.1% in the experimental group (n = 68) and 78.9% in the control gro

180 andomized into 2 parallel arms comprising an experimental group (n = 88), fed foods prepared from bio

181 Animals were randomized into shPHD2 experimental group (n=25) versus shScramble control grou

182 A 5-mm-diameter CSD was created and three experimental groups (n = 10) were randomly assigned base

183 n plus an active impedance threshold device (experimental group, n = 15).

184 t online movements of hand and arm orthoses (experimental group, n = 16).

185 took part in a task that heightened stress (experimental group, n = 41) or in which they did not tak

186 ed to the surface of sound dentin disks in 4 experimental groups: non-antibacterial adhesive and gent

187 [non-inferiority margin] at 5 years for each experimental group; non-inferiority was shown if the upp

188 gp140 trimers was included as a comparative experimental group of NHPs.

189 Four experimental groups of adult male C57BL/J mice were expo

190 n HIV-1 viral load when analyzed across four experimental groups of BLT mice.

191 focused on disease classification, comparing experimental groups of effected to normal patients.

192 Of all three experimental groups, only mice expressing IkappaKca show

193 best respiratory-system compliance (n = 501; experimental group) or a control strategy of low PEEP (n

194 help equally often from an out-group member (experimental group) or an in-group member (control group

195 January 2006 to December 2010, the covered (experimental group) or bare stent (control group) was us

196 oney over the next 4 weeks either on others (experimental group) or on themselves (control group).

197 ral feeding with an immunonutrition formula (experimental group) or standard formula (control group)

198 ly, rats self-administered either a cocaine (experimental group) or sucrose (control) during 12 conse

199 tients were assigned to the 4-month regimen (experimental group) or the standard regimen (control gro

200 Defects were treated with BPBM/GTR/PRP (experimental group) or with BPBM/GTR (control group).

201 decrease in lung signal was observed in each experimental group over 24 h.

202 tis B surface antigen (HBsAg) in control and experimental groups over the first 48 weeks of the study

203 ference in histologic findings between the 2 experimental groups ( P > 0.05).

204 roup and in 115 of 142 patients (81%) in the experimental group (P > 0.05).

205 pt mean GBI, were significantly lower in the experimental group (P <0.05).

206 ater than in the non-sonicated brain for all experimental groups (p<0.0001), and 1.5-fold higher for

207 Moreover, the experimental groups presented enhanced excitability of t

208 andard CLOSE protocol (35 W), whereas in the experimental group, pulmonary vein isolation was perform

209 Further analyses showed that men in the experimental group rated a significantly heavier female

210 f the instructive placebo procedure, the two experimental groups reached higher levels of force, beli

211 The experimental group received a 1-year intervention design

212 Participants in the experimental group received a 3-month multidisciplinary

213 andomly assigned to one of three groups: The experimental group received an individualized telephone

214 The experimental group received orally dosed PRT318, whereas

215 The experimental group received the polymeric device inserte

216 The experimental group received twelve magnocellular based v

217 Patients in the experimental groups received perfusion of the drug every

218 Experimental groups received vehicle, dexamethasone, or

219 Firefighters were randomly divided into 6 experimental groups receiving 1.2, 2.4, or 3.6 g flax oi

220 her maintained or switched resulting in four experimental groups: regular chow (R), high fat diet (H)

221 tes were 0.96% and 0.90% for the control and experimental groups, respectively.

222 sed BH4 in retinas, lungs, and aortas in all experimental groups, resulting in a dose-dependent decre

223 Moreover, the experimental group showed brain-behavior relationships r

224 The DG experimental group showed increased freezing in the orig

225 The experimental group showed significant improvements in ma

226 esults Compared with bare nanoparticles, all experimental groups showed significantly increased negat

227 Both experimental groups showed that aromatase is localized i

228 nal HSCs and can accommodate a wide range of experimental group sizes.

229 hotopic in vivo studies often requires large experimental group sizes.

230 unt data were analyzed by nested ANOVA for 5 experimental groups, split-mouth controls, 3 levels alon

231 Compared with the control group, the experimental group strategy increased 6-month mortality

232 ilesional lateral geniculate nucleus in both experimental groups, suggesting that postlesion visuomot

233 es in aromatase distribution between the two experimental groups suggests that these localization pat

234 Animals were allocated into two experimental groups: t-extracorporeal cardiopulmonary re

235 The PCB levels were reduced in all of the experimental groups tested, where addition of starter cu

236 r a control group (no thalidomide) or to the experimental group (thalidomide during induction, betwee

237 mpletion, MCP-1 levels remained lower in the experimental group than in the control group (313.88 vs

238 verse event was significantly greater in the experimental group than in the control group (p<0.0001);

239 ents, the increase in BMI was smaller in the experimental group than in the control group after a 1-y

240 l group at 1 year, and remained lower in the experimental group than in the control group at 2 years.

241 MDA levels were higher in all experimental groups than in group C, but significant in

242 es into holes, subjects were assigned to two experimental groups that were given different kinds of e

243 deo was shown on a tablet to children in the experimental group the afternoon preceding a planned sur

244 In participants in the experimental group, the hemodynamic response in the amyg

245 For the experimental group, the largest RMSDs were 1.1 mm in ant

246 In the experimental group, the preservation solution was aerate

247 For the experimental group, the templates were designed based on

248 Among the other experimental groups, there was no change in kidney uptak

249 ately after the baseline EGG (5 pigs in each experimental group): thiopental, isoflurane, nitrous oxi

250 opulation precludes experimentation on large experimental groups, those examined in our study indicat

251 s suitable for examining differences between experimental groups, though, as with any method for imag

252 intraperitoneally before suture only in the experimental group to facilitate the fusion of the oment

253 For example, DAS has enabled small experimental groups to integrate their data into the Ens

254 hange in a control group with weight loss in experimental groups told to eat breakfast or to skip bre

255 ssion of CKD, we used two groups of rats: an experimental group undergoing 5/6 nephrectomy only and a

256 The experimental group underwent localized accelerations at

257 nts were enrolled and divided into 2 groups: experimental group (using genioplasty templates) and con

258 We included 4 experimental groups: vehicle-treated animals with extrac

259 al was 13.3 months (95% CI 11.7-14.2) in the experimental group versus 11.6 months (11.0-12.7) in the

260 ypertension (88 [27%] of 332 patients in the experimental group vs 67 [20%] of 329 patients in the st

261 verse events were diarrhoea (41 [10%] in the experimental group vs five [1%] in the control group), n

262 Lower mortality in the experimental group was also found among the least educat

263 One experimental group was conditioned about the effects of

264 baseline activity was recorded and then the experimental group was injected with amphetamine (0.6mg/

265 The experimental group was injected with MSCs (0.3x10(6)) in

266 The experimental group was injected with PTH (80 mug/kg) dai

267 Between-groups analyses showed that the experimental group was matched with the control group in

268 e of secondary interventional therapy in the experimental group was significantly lower than that in

269 Enrollment in the experimental group was stopped when the 85% Bayesian pre

270 e we observed behavioral idiosyncrasy in all experimental groups, we suspect it is present in most be

271 At 6 mo, serum ucOC concentrations in the experimental group were 0.96 +/- 0.08 ng/mL compared wit

272 The rats in the experimental group were fed 30 mg/kg CsA daily for 4 wee

273 Those in the experimental group were found to have significantly grea

274 patients in the placebo group and 140 in the experimental group were included in the final analysis.

275 Those in the experimental group were rewarded for responding to subst

276 x/ascites (6.9% vs. 16.5%, P = 0.019) in the experimental group were significantly lower than those i

277 All three experimental groups were able to utilize the embedded pr

278 Experimental groups were as follows: unchallenged contro

279 Experimental groups were compared at baseline, day 2, 1

280 Four experimental groups were evaluated: control (nontreated)

281 All experimental groups were exposed to 3 lighting condition

282 Two experimental groups were instructed that treatment with

283 In total, 401 experimental groups were manually annotated from 74 peer

284 Two experimental groups were prepared.

285 erent commercial meat starter cultures, five experimental groups were prepared: no further addition;

286 Five experimental groups were prepared: unstimulated T cells,

287 The experimental groups were stimulated three times per minu

288 In addition, teeth with PCCR (experimental group) were matched with contralateral teet

289 No MMNm responses were recorded in either experimental group when stimuli were presented at SOAs f

290 p (n=6; 18 individual zones of ablation) and experimental groups where antennas were spaced 2.5 cm (n

291 s were detected between samples derived from experimental groups which experienced fearful or neutral

292 d only tooth extraction (EXT n = 27), or the experimental group, which received ARP using a combinati

293 f 10 mg/kg rifampin, followed by consecutive experimental groups with 15 patients each receiving rifa

294 An experiment containing three experimental groups with eight subjects each can take as

295 rol group with uninjured lungs (n = 4) and 2 experimental groups with surfactant deactivation induced

296 e 120 min whisker stimulation period in four experimental groups with treatment initiated 0, 1, 2 (pr

297 37 cytokines increased significantly in all experimental groups, with 21 cytokines showing the highe

298 ional level, we found lower mortality in the experimental group within the strata that settled for co

299 Adaptive assignment to experimental groups within each disease subtype was base

300 We hypothesized that the experimental group would gain weight at a slower rate th